The Lm-1 locus controls the expression of one or more cell surface alloantigens recognized by cytotoxic T lymphocytes (CTL). ~ Earlier studies showed Lm-1 is Igh-linked and located five map units telomeric to Pre-I on chromosome 12 (1). Two Lm-1 alleles (Lm-1 a and Lm-1 b) were identified, and lipopolysaccharide (LPS) blasts from 46 strains derived from crosses between Lm-I a and Lm-1 b mice were typed. 37 of these strains were known to have genetic recombinations in the telomeric region of chromosome 12. None of the recombinations divided the Lm-1 locus; i.e., all strains typed unambiguously as either Lm-I a or Lm-I b. Accordingly, if Lm-I were to consist of more than one gene, such genes would have to be closely linked.
Spleen cells were suspended in Hank's balanced salt solution (HBSS), emulsified in complete Freunds adjuvant (CFA), and injected intraperitoneally (1/5 spleen per mouse) into congenic mice. 2 wk later, immunized mice were boosted with the same dose of spleen cells in HBSS (without CFA), rested for 2 too, then boosted again with spleen cells in HBSS at monthly intervals. There was a 2-wk period between the last immunization and sacrifice. We did not detect anti-Lm-t antibodies in any mice, even after prolonged immunization.
Generation of Cytotoxic Effector Cells
Following procedures described previously (4), single-cell suspensions were prepared from spleens of immunized mice (for anti-Era-1 effectors) or normal C57BL/6 mice (for anti-H-2 a effectors), and from spleens of the immunizing strain (stimulator cells). Erythrocytes were lysed by treatment with NH4Cl (5). Effector cells (at 5 x 106 cells/ml) were mixed with equal volumes of cesium-irradiated stimulator cells (2,000 rad), also at 5 x 10 ~ cells/ml, in Costar 3075 tissue culture flasks (16 ml/flask), and cultured for 6 d in a 37°C humidified incubator. The culture medium consisted of RPMI 1640 (Microbiological Associates, Walkersville, MD), 10% fetal calf serum (Microbiological Associates), 5 x 10 -5 M 2-mercaptoetbanol, 50 ug/ml gentamycin (Schering Corp., Union, NJ), 10 mM Hepes, pH 7.2, (Gibco, Grand Island, NY), and 2 mM glutamine.
Preparation of Target Cells and Splenic LPS Blasts
Cell suspensions of normal spleen cells (erythrocytes lysed by NH4CI treatment) were cultured at 5 x 10 ~ cells/ml 10 #g/ml with S. typhosa LPS, W (Difco Laboratories, Inc., Detroit, MI) for 3 d before labeling with 5JCr. Where T cell depletion is indicated, the adherent fraction from a nylon wool column (6) , was recovered by adding cold medium and compressing the column with a syringe plunger.
Splenic T Cell Blasts
Spleen ceils were fractionated by nylon wool filtration according to the method of Julius et al. (6) . The effluent fraction was cultured at 5 X 106 cells/ml with 5 ttg/ml Con A (E. Y. Laboratories, San Mateo, CA) in Costar 3075 tissue culture flasks for 2-3 d at 37°C before use as targets.
Thymocyte Blasts
Thymocytes were cultured at 5 x 106 cell/ml in medium containing 50% supernatant ofconcanavalin A (Con A)-stimulated spleen ceils (Con A SN)at 37°C for 3 d before ~Cr labeling as described above. Con A SN was prepared by harvesting the supernatant of Con A activated mouse spleen cells after 48 h in culture as described previously (7) .
Fibroblast Targets
Fibroblast cultures were derived from explants from the subcutaneous connective tissue of 3-mo-old BALB/c and C.B-17 mice. Explants were originally cultured in 60-mm petri dishes (Falcon Labware, Oxnard, CA) under drops of RPMI media supplemented as described above. After 24 h, media (3 ml) was added to dishes, and the cultures were fed every 4 d. After 2 wk, fibroblasts were harvested by incubation with trypsin EDTA solution (Gibco, Grand Island, NY) and passed into Costar 3075 culture flasks. Cells were passaged when grown to monolayers, and used as targets from I to !.5 mo after culture initiation.
Macrophage Targets
Mice received an intraperitoneal injection of 2 ml 3% thioglycollate medium (Difco Laboratories) 4 d before sacrifice. Peritoneal cells were harvested by lavage and plated in flat-bottom 96-well culture plates (Costar 3596) at l0 b cells/200 #l/well. Cells were incubated overnight and washed once before use as targets.
Measurement of Macrophage Death
Following the methods of Parish and Mullbacher (9), macrophage monolayers were overlaid with the various concentrations of effector cells. After a 6-h incubation, the plates were washed once with HBSS. The number of live macrophages remaining adherent was quantitated by measuring the uptake of neutral red. To each well, 200 #1 of 0.036% neutral red (Polysciences, Inc., Warrington, PA) was added. Plates were placed at 37°C for 15 min. The neutral red solution was decanted, and the wells were washed by submerging the plates three times in phosphate-buffered saline, and inverting the plates on paper towels between each wash. The macrophages were then solubilized by the addition of 200 t~l of 0.5% sodium dodecyl sulfate in 0.05 M acetic acid to each well. The neutral red released from the macrophages was quantitated by measurement of optical density (OD) by a micro-ELISA (enzyme-linked immunosorbent assay) autoreader MR580 (Dynatech Laboratories, Alexandria, VA) with test wavelength 540 nm and reference wavelength 630 nm. Percent specific lysis (SL) was calculated as 100 x (control -test)/ control, where control = OD with no effector cells present, and test = OD with effector cells present.
In this assay, both lysis and detachment of adherent macrophages caused by antigenspecific effector cells were scored as cell death. While detached macrophages are functionally compromised, they may not yet be lysed. However, as the amount of neutral red uptake was strictly correlated with the presence (or absence) of the appropriate antigen-specific effector cells, we consider this assay a valid and reliable way to detect Lm-1 determinants on macrophages. The results were recorded as percent SL.
5~Cr Labelling of Targets
Cells were suspended in 100 ul of fetal calf serum (FCS) and 100 gCi Na251CrO4 (New England Nuclear, Boston, MA), and incubated at 37°C for 1 h. The cells were then washed three times to remove free isotope. Targets were suspended at 10 ~ cell/ml in RPMI 1640 with 20% FCS, and 100 #l/well were assayed for lysis in the cytotoxicity assay.
5~Cr-release Assay
After 6 d in culture, the effector cells were harvested and tested in a standard 51Cr-release assay (8) . All results are reported as percent SL, which is calculated as 100 × (experimental release -spontaneous release)/(maximum release -spontaneous release), where experimental release is cpm 5~Cr released in the presence of effector cells. Maximum release is determined by detergent lysis. All values reported represent the mean of quadruplicate measurements. In all cases, the SE was <5% and is, therefore, not given.
For each experiment shown, four fivefold dilutions of effectors were tested against a fixed number of targets. The starting effector/target ratio (E:T) was between 100:1 and 50:1. Except for cold-target inhibition experiments, (see below) data are reported as percent SL at the highest E:T ratio only. This ratio was chosen to demonstrate that, even at the highest E:T ratio, the targets that we have designated as negative for lysis are truly negative. However, when a given target is susceptible to lysis, the percent SL at the lowest E:T ratio was usually at least 50% that seen at the highest E:T ratio. The E:T ratio used to obtain the given values are noted in the table.
Cold-target Inhibition of Anti-Lm-1 Effector Cells
Effector cell lysis of labeled target cells was inhibited by addition of unlabeled target cells. Effector cell cultures were sampled on the fifth day, and the cells were titrated against a fixed number of labeled target cells to determine limiting effector/labeled target ceil ratios (E:T'); i.e., the smallest ratio still to give significant lysis of labeled targets. In different experiments, limiting E:T' ratios ranged from 5:1 to 0.15:1, and they are noted in the legends. On the sixth day of culture, effector cells were harvested for cold-target inhibition assays (14) . Varying numbers of unlabeled target cells were added at limiting E:T' ratios. The ratio of unlabeled/labeled target cells (T:T') is indicated in the figures.
The procedure for each assay was as follows. Effector cells (100 #1) were added to microtiter wells, followed by unlabeled target cells (50 #1). Labeled target cells (also in 50 #1) were added last. The cells were gently pelleted by centrifugation for 4 rain at 300 rpm, and incubated for 3-4 h. Percent inhibition of lysis by unlabeled target cells is calculated as 100 X [1 -(percent SL with added T)/(percent SL with no added T)]. Percent SL is given as the mean of quadruplicate determinations for each indicated T:T' ratio. In all experiments shown, the SE was <3%, and therefore is not given.
Fluorescence-activated Cell Sorter (FACS) Analysis
Cells were labeled with an optimal amount of fluorescein isothiocyanate (FITC)-conjugated monoclonal rat anti-Thy-l.2 antibody (10), or FITC-conjugated goat antimouse (Fab)2 sera (Cappel Laboratories, Cochranville, PA). All unreacted antibody was removed by washing, and the cells were analyzed with a FACS II system (Becton Dickinson and Company, Sunnyvale, CA), using 488 nm laser illumination.
In Vivo Cell Transfers
One day before cell transfer, recipient mice received 600 tad irradiation from a X-ray source under the following conditions: 225 kV; filtration 1 mm AI and 0.5 mm Cu; dose rate 35-40 rad/min. Mice were injected intravenously with 0.5 ml HBSS containing 107 spleen cells and 2 x 106 bone marrow cells. At various times thereafter, they were bled, and the sera were tested for Igh allotype markers.
Antiallotype Assay
The expression of Igh allotypes was assayed by means of immunoprecipitation in Ouchterlony microplates. The preparation of these antisera and their specificity has been described previously (15) .
Results
Expression of Lm-1 Determinants on Splenic T Cell Blasts and Activated Thymocytes. 51Cr targets were prepared from splenic T cell blasts, fresh thymocytes, and thymocytes after 1, 2, and 3 d of in vitro culture with Con A SN. Splenic B cell blasts were included as controls. Targets were tested for susceptibility to lysis by both anti-Lm-1 effectors and anti-H-2 d effectors. All targets were lysed by anti-H-2 d effectors (Table I) . Anti-Lm-1 a effectors killed both splenic T and B cell blasts from the Lm-1 a strain, C.B-31 (Table I) (Table I) . Activation with Con A SN, therefore, results in the conversion of thymocytes from Lm-l-to Lm-1 +. 2H4, were both tested for Lm-1 expression. Neither cell line could stimulate, nor be lysed by, anti-Lm-1 b effectors (Table II) . Controls show that both T cell clones could stimulate and be lysed by anti-H-2 ~ effectors. We consider these clones (Thy-l.2 +, Lyt-1 ÷, Lyt-2 +) examples of immature T cells, as they were derived from two independent thymic T cell lymphomas of C.B-17scid mice. These mice lack functional T cells (11) .
Two Independent Cultured Lines of Thymic T Cell Lymphomas Do Not Express

Variable Expression of Lm-1 Determinants on Pre-B Cell Lines Induced by A-
MuLV.
A number of A-MuLV-induced cell lines of early B cell phenotype were tested for susceptibility to lysis by anti-Lm-1 effectors. With respect to cell lines of C.B-17 origin, C.BAbl-7853, C.BAbI-11, and C.BAbl-15 expressed Lm-1 determinants, and lines C.BAbI-17 and C.BAbl-7 did not. Of the cell lines of C.B-17scid origin, SAbI-11 and SAbl-12 were Lm-1 +, and SAbl-3 was Lm-1- (Table III) . All targets were susceptible to lysis by anti-H-2 d effectors.
Expression of Lm-1 Determinants on Macrophages but Not on Fibroblasts.
AntiLm-I ~' and anti-Lm-1 b effectors were tested for the ability to kill macrophages from both LM-1 a and Lm-1 b strains. Anti-L/n-l" effectors killed macrophages from the Lm-1 a strains, BALB/c, C.B-39, and C.B-31 but not from the Lm-1 b strains, C.B-17 and C.B-26 (Table IV) . Conversely, anti-Lm-1 b effectors lysed macrophages from C.B-17, C.B-26 (Table IV) , and C.B-17scid mice (data not shown). The results shown in Table IV on Lm-1 expression by macrophages were obtained using the neutral red assay described in Materials and Methods. This assay was chosen to demonstrate clearly the phagocytic ability of the target cell. However, these results have been repeated using a conventional 5~Cr release assay with labeled, thioglycollate-induced, peritoneal adherent cells as targets (data not shown).
Fibroblast lines derived from the Lm-1 ~ and Lm-1 b strains were also tested for susceptibility to lysis. As shown in Table IV , these lines were lysed by anti-H-2 a effector cells but not by anti-Lm-1 effectors cells. Not shown is that fibroblasts were unable to substitute for spleen cells as in vitro stimulators of anti-Lm-1 effectors. Further evidence that fibroblasts do not express Lm-1 determinants 
C.B-17scid
SAbI-11 33 0 45
SAbI-12 32 0 27
SAbl-3 0 0 57 * E:T = 80:1. * E:T = 100:1. comes from cold-target inhibition studies. BALB/c fibroblasts did not inhibit the killing of BALB/c LPS blasts by anti-Lm-1 ~ effectors, but did inhibit killing by anti-H-2 a effectors (data not shown).
A Common Lm-1 Determinant on T and B Cells that Is Not Expressed on Pre-B
Cells. The ability of thymocyte blasts and splenic B cell blasts to inhibit the lysis of labeled thymocyte blasts is shown in Fig. 1 . Both sources of unlabeled blasts inhibited anti-Lm-1 b (Fig. 1A) and anti-Lm-1 a (Fig. IB) effector cell lysis by ~80% at T:T' ratios _ 10:1. This inhibition was Lm-1 specific, since unlabeled blasts of the alternative Lm-1 allele did not inhibit lysis. Results similar to those of Fig. 1 were also obtained when purified populations of unlabeled splenic T and B cells were used to inhibit lysis of splenic T cell blasts (data not shown).
In contrast to B cell blasts, the Lm-1 + pre-B cell lines, SAbl-11 and C.BAbl-7853, failed to inhibit effector cell lysis of thymocyte blasts even at T:T' ratios of 20:1 (data shown for SAbi-11 only) (Fig. 1B) . We conclude there is an Lm-1 determinant common to both T and B cells that is apparently not expressed on LM-1 b-positive pre-B cells. We tentatively designate this determinant Lm-1.1 for Lm-1 a strains and Lm-l.11 for Lm-1 b strains.
A Common Lm-1 Determinant on Pre-B and B Cells that Is Not Expressed on T
Cells. Cold-target inhibition experiments were also performed using the Lm-lb pre-B cell lines, SAbI-11 and C.BAbl-7853 as the labeled target cells. As shown in Fig. 2 , B cell blasts were more effective inhibitors of pre-B cell lysis than the pre-B cells themselves. This difference is presumably due to a higher density of Lm-1 determinants on B cells relative to pre-B cells. Nonetheless, both sources of unlabeled targets inhibited lysis (percent inhibition _>70% at T:T' ratios of 10:1). Thymocyte blasts, on the other hand, were ineffective inhibitors of pre-B cell lysis. Maximal inhibition in this case was <30%. These data indicate that Unlabeled-to-labeled target cell ratio there is another Lm-1 determinant, common to both pre-B and B cells, but absent from T cells, or poorly expressed on such cells. This determinant will be designated Lm-1.2 for Lm-1 a strains and Lm-1.12 for Lm-1 b strains.
Inability of Pre-B and T Cells to Inhibit Lysis of B Cells.
Reciprocal experiments to those of Figs. 1 and 2 are shown in Fig. 3 . Here, we compare the ability of pre-B cells, B cell blasts, and thymocyte blasts to inhibit anti-Lm-1 effector cell-mediated lysis of labeled B cell blasts. The inhibition observed with pre-B cell inhibitors was always neglibible, and that observed with thymocytes was usually _<15% at T:T' of 20:1. Purified populations of splenic T cell blasts and SAbl-11 pre-B cell line also failed to inhibit lysis (data not shown). Occasionally, some inhibition (20-30%) was observed when Lm-1 a T cells were tested as inhibitors (Fig. 3A) . The reason for this is not clear, but it might be explained by contamination of the B cell target preparations with T cells.
Our interpretation of the results in This interpretation helps explain the apparent differences in lytic efficiency with which anti-Lm-1 effectors lysed B cell blasts, thymocyte blasts and the pre-B cell lines. This is indicated by the limiting E:T' ratios for each labeled target in the legends of Figs. 1, 2, and 3. As can be noted, B cell blasts were lysed ~ 10 times more efficiently than thymocyte blasts, and ~25 times more efficiently than pre-B cells (the mean E:T' ratio for B cell blasts was 0.15:1 vs. 1.5:1 for thymocyte blasts, and 4:1 for pre-B cells).
Effect of Mixtures of T and Pre-B Inhibitors on B Cell Lysis.
The data in Fig. 3 leave open the possibility that B cells may express a third Lm-1 determinant distinct from both Lm-l.1 (Lm-l.11) and Lm-l.2 (Lm-l.12). We attempted to test this by inhibiting B cell lysis with mixtures of T and pre-B cells. As shown in Table V 
Genetic Linkage of Lm-l.1 and Lm-l.2 (and Lm-l. ll and Lm-l.12) Determi-
nants. The demonstration of distinct Lm-1 determinants suggested that separate genes might code for these determinants and that these might have segregated in strains known to be chromosomal recombinants in the region near Lm-1. Therefore, thymocyte and B cell blasts were prepared from ten of the recombinant strains that were most informative in the previous Lm-i mapping study (1) . Each Cell type was tested for susceptibility to lysis by both anti-Lm-1 a The results were striking, as shown in Table VII . Control recipients (groups C, D, H, I, and J) showed Igh-allotype production by B ceils from the bone marrow graft within 3-13 wk after cell transfer. Whereas, with one exception, no detectable Igh allotypes of bone marrow graft origin appeared in this time period in experimental groups that received anti-Lm-1 immune ceils (A and E). were cotransferred with bone marrow cells of a different Lm-1 type, the appearance of Igh allotype from the bone marrow graft was delayed (Table VII , groups B and G compared to C and H). 7 mo after cell transfer, Igh allotype production by donor bone marrowderived cells was observed in some recipients (Table VII, groups A and E) indicating that successful engraftment of bone marrow cells occurred in at least some (if not all) recipients. The implications of this are considered in the Discussion.
Discussion
Expression of Distinct Lm-1 Determinants on Different Cell Types. We have shown that antigenic determinants encoded by the Lm-i locus are expressed on B and T cell blasts, some pre-B cell lines, and macrophages. That expression of these determinants is dependent on the stage of cell differentiation or state of cell activation is inferred from the following: First, Lm-1 determinants are not detected on fibroblasts (Table IV) . Lm-1 is not, therefore, a constitutive membrane protein of all cells. Also, we have found immature B and T cell lines that do not express Lm-1 determinants (Tables II and III) . Unstimulated thymocytes also do not express Lm-1 determinants, whereas thymocyte blasts and splenic T cell blasts are Lm-1 + (Table I) . These results indicate that Lm-1 is a differentiation antigen that is expressed by lymphoid cells as they mature.
We have shown that distinct Lm-1 determinants are differentially expressed on T, pre-B, and B cells. Two Lm-1 determinants were defined on the basis of cold-target inhibition assays. These were designated Lm-1.1 and Lm-l.2 for Lm-I a mouse strains and Lm-l.ll and Lm-l.12 for Lm-1 b mouse strains. Lm-1 bexpressing T, pre-B, and B cells typed Lm-1.11 +/Lm-1.12-, Lm-1.11 -/Lm-1.12 +, and Lm-1.11 +/Lm-1.12 +, respectively. Similarly, Lm-l"-expressing T and B cells typed Lm-l.l+/Lm-l.2 -and Lm-l.l+/Lm-l.2 +, respectively. Lm-1 a pre-B cell lines from the Lm-I ~ congenic strains, BALB/cAnNIcr or C.B-31, were not available, but presumably express only Lm-l.2. Evidence for a third Lm-1 determinant on B cells was presented (Table V) , but confirmation awaits the availability of Lm-1-specific T cell clones.
Whether a given determinant is detected may depend on the immunization protocol used to generate effector T cells. For example, with our protocol, which included the use of adjuvant, mice had to be immunized at least four times to obtain effector cells that lysed macrophages, whereas two immunizations were sufficient to generate effector cells that lysed T, B, and pre-B cells (data not shown). Since the increased number of immunizations did not increase the number or efficiency of CTL specific for lymphocytes, these data suggest that macrophages may express an additional Lm-1 determinant.
The Lm-1 Locus and its Relationship to Other Igh-linked Alloantigens. The finding that different immunization protocols may result in the detection of distinct determinants suggests an explanation for reported differences on the cell distribution of Igh-linked alloantigens detected by CTL. As mentioned in the introduction, two other reported (2, 3) cell-surface antigens, H-40 and H(CH), are encoded by genes on chromosome 12, telomeric to Igh. Like Lm-1, both are defined as a target antigen in a CTL assay. Their map position relative to Lm-I and/or Pre-I has not yet been determined. However, given our preliminary evidence (Table V) for a third Lm-1 determinant on B cells, it is possible that H-40 (2) is a B cell-specific member of the Lm-1 family of determinants. Similarly, H(C,) (3), which is expressed on both B and T cell blasts, may correspond to Lm-l.1. Lm-1, H-40 , and H(C~) may all be members of a genetic complex that codes for a family of lymphoid and macrophage differentiation antigens. Forman et al. (2) have found that H-40 expression accompanies surface Ig expression, and have suggested therefore that H-40 is important in B cell function. Given our data on the complexity of the Lm-1 antigen system, the pattern of expression of these antigens and their modulation during lymphocyte activation, it seems likely that the Lm-1 locus is important for the function and interaction of lymphocytes and macrophages.
In addition to H-40 and H(CH), there is another cell surface antigen encoded on the telomeric portion of chromosome 12 that could also be a member of the Lm-1 family of antigens. The gene for the chemically induced, tumor-specific transplantation antigen, Meth A, has been mapped to the teiomeric portion of chromosome 12 (16) , probably telomeric to Pre-1 (see ref. 1). Biochemical analyses of different methylcholanthrene-induced, tumor-specific transplantation antigens has led DuBois et al. (17) to propose that the Meth A antigen itself is the product of a member of a multigene family. In independent studies, Flood et al. (18) reported evidence that the Meth A antigen is serologically crossreactive with T cell-derived factors. This suggests that the normal homologue of Meth A is involved in lymphocyte function. These data strengthen our hypothesis that the telomeric end of chromosome 12 codes for a family of cell surface antigens that play a role in the differentiation and function of lymphocytes and macrophages.
Lm-1 is similar in many ways to the T-200 family of antigens (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Cellspecific antigenic determinants of the T-200 family have been identified for T cells, B cells, and macrophages (25) (26) (27) . Thus, T-200 shares with Lm-1 the characteristics of lymphocyte-macrophage specificity (22) , regulated expression during differentiation (28) , and differential expression of distinct antigenic determinants (25) (26) (27) . These characteristics have made the T-200 antigen system of interest to many who study hemopoiesis, lymphocyte differentiation, and the function of cell-specific membrane molecules (25) (26) (27) (28) (29) (30) .
Despite their similarities, Lm-1 and T-200 can be distinguished on genetic grounds. Lm-1 is coded by one or more genes on chromosome 12 (1), whereas Ly-5, an antigenic determinant common to all members of the T-200 family, is coded by a gene on chromosome 1 (23, 24, 31) . Lm-1, therefore, represents a newly identified antigen system whose potential usefulness to the study of lymphoid and myeloid differentiation resembles that of T-200.
The molecular basis for distinct Lm-1 (or T-200) determinants is not understood. Different Lm-1 determinants might result from cell-specific modification of one or more Lm-1 polypeptides before insertion into the membrane. Precedent for this idea comes from a number of systems. Thy-1 molecules show differences between cell types due to posttranslational modification (32) , and differences in function between Ia molecules on B cells and macrophages have been associated with carbohydrate moieties (33) . Also, evidence that the same T-200 molecule can display different antigenic determinants (26) is consistent with this idea. Each Lm-1 determinant, on the other hand, could represent a separate gene product in the form of a single polypeptide or heteropolymer on the cell surface. Such Lm-I genes would have to be closely-linked (Table VI) , and presumably would be structurally and functionally related.
Effects of Lm-l-incompatibility on B Lymphocyte Function. Cell transfer experiments showed that anti-Lm-1 T cells (presumably CTL) can prevent Igh allotype production in vivo. Injection of X-irradiated Lm-lb recipients with bone marrow cells from Lm-1 ~ mice together with anti-Lm-l"-specific spleen ceils resulted in inhibition of Igh a allotype production of the bone marrow-derived donor B ceils. Similar results were obtained in the reciprocal experiment. The bone marrow grafts were apparently not rejected, as is evident from the appearance of Igh a (or lgh b) allotype in some recipients 7 mo after cell transfer. To explain these results we reason as follows: X-irradiated recipients were engrafted with Lm-1-stem cells from the bone marrow graft (that such cells exist is inferred from our detection of Lm-1-A-MuLV pre-B cell lines). As progeny of these stem cells matured and expressed Lm-1 determinants, they were killed (or suppressed) by anti-Lm-1 effector cells. However, with the presumed death of donor anti-Lm-1 effector cells 5-7 mo after cell transfer, some bone marrow stem cells were able to differentiate into Lm-1 ÷, Igh-producing B cells. Their ability to do so may have depended on whether the host had become tolerant or immune to cells expressing the foreign Lm-1 determinants.
Although we did not test the above recipients for Lm-l-expressing macrophages and T cells of donor bone marrow origin, it seems likely that differentiation and maturation of these cell types may also have been prevented or inhibited.
Finally, the implications of Lm-l-incompatibility are worth noting. Incompatibility at the Lm-1 locus could help explain the previously observed Igh-linked restriction in T-B and T-T cell-cell interactions (34) (35) (36) (37) (38) (39) (40) . For example, reports that the induction (34, 35) or activity (37) ofT cell-suppressor factors is restricted by Igh-linked genes may in fact reflect a restriction imposed by Lm-1 or other closely-linked loci. Further, the lack of synergy observed by L'Age-Stehr (38) between T and B cells of C.B-17 and BALB/c mice may have been due to antiLm-l-specific T cell aggression against B cells. Second, relevant to bone marrow transplantation in general, incompatibility at Lm-1 and its human counterpart could contribute to graft-vs.-host disease, and/or could severely impair the growth and differentiation of engrafted stem cells.
Summary
Lm-1 is an Igh-linked locus that codes for cell surface alloantigens (Lm-1 determinants) recognized by T lymphocytes. Using Lm-1 congenic strains and cold-target inhibition of anti-Lm-l-specific lysis by cytotoxic T lymphocytes, we were able to demonstrate differential expression of two distinct Lm-1 antigenic determinants. One determinant is expressed on the surface of T cell blasts, the other on a number of pre-B cell lines. Both determinants are present on B cell blasts. Macrophages also bear Lm-1 determinants, and possibly express a determinant not found on lympbocytes. Fibroblasts, (unstimulated) thymocytes, and immature T cells lack detectable Lm-1 determinants. These data indicate that expression of the Lm-I locus is dependent on cell lineage and the stage of cell differentiation or activation. We propose that Lm-i is a lymphocyte-macrophage differentiation locus containing a number of structurally and functionally related genes.
Evidence was presented that Lm-I may also serve as a histocompatibility locus of major importance for bone marrow transplantation. Specifically, when Lm-1-incompatible bone marrow cells and spleen cells (from normal or anti-Lm-1 immune mice) were transplanted into X-irradiated recipients, the maturation and/or function of bone marrow-derived donor B cells was delayed or inhibited.
